Veradigm

Veradigm Equity Turnover

The Equity Turnover of Veradigm (MDRX) as of Nov 4, 2026 is 0.58. In the previous year, Equity Turnover was 0.58 — a change of 0.00% (lower).

Equity Turnover

0.58

YoY

0.00%

Last updated:

Equity Turnover of Veradigm is 2024 0.58 . Equity Turnover of Veradigm was 2023 0.58 . It decreases by 0.00% lower compared to the previous year.

The Veradigm Equity Turnover history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity Turnover
Date
Equity Turnover
Jan 1, 2016
1.26 USD
Jan 1, 2017
1.34 USD
Jan 1, 2018
1.11 USD
Jan 1, 2019
1.27 USD
Jan 1, 2020
0.90 USD
Jan 1, 2021
0.41 USD
Jan 1, 2022
0.58 USD
Jan 1, 2024
0.58 USD
The Veradigm Equity Turnover history
YEAREquity TurnoverYoY
0.580.00%
0.58+40.93%
0.41-54.53%
0.90-29.01%
1.27+14.72%
1.11-17.13%
1.34+6.25%
1.26+28.71%
0.98-8.94%
1.07—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Veradigm Stock analysis

What does Veradigm do? Allscripts Healthcare Solutions Inc is one of the leading companies in the digital healthcare sector in the USA. The company was founded in 1982 and has since become one of the most important providers of IT solutions in healthcare. Allscripts supports healthcare providers in improving patient care and efficiency through the development and provision of innovative software and IT solutions. The business model of Allscripts is based on the development and sale of web-based software solutions for medical documentation and hospital management. These solutions are mainly distributed to hospitals and practices through subscriptions or licenses. Allscripts offers a variety of products that focus on various areas of medical care. One of the main divisions of the company is the electronic health records system (EHR). This system allows for the electronic recording, storage, and management of medical data and information. This enables healthcare providers to quickly and easily access patient information and document important diagnoses and treatments. Another important division of Allscripts is the Revenue Cycle Management (RCM), which optimizes billing and payment processes in hospitals and practices. In addition, Allscripts also offers solutions for telemedicine, including patient portal applications, remote patient monitoring systems, and mobile apps for patients and providers. Allscripts is based in Chicago and employs over 10,000 employees in various countries. The company also maintains partnerships with other companies in healthcare to facilitate and improve the complexity of digital transformation in the healthcare market. This includes companies like Microsoft, who work together with Allscripts on the development of artificial intelligence for healthcare applications. Allscripts' portfolio of offerings is very broad and provides customers with a variety of software solutions for different areas of medical care. The products are particularly characterized by their user-friendly interfaces, flexibility, and scalability. This allows customers to customize the solutions to their specific needs and consider future requirements. However, some products have been criticized for their expandability, poor design, and slow loading times. Recently, Allscripts has made a number of investments in research and development to address these issues and optimize the applications. In summary, Allscripts Healthcare Solutions Inc is considered one of the leading providers of software and IT solutions in healthcare in the USA. Thanks to a wide range of products and close collaboration with partners in healthcare, Allscripts is able to offer its customers innovative and scalable solutions that help them optimize their business processes and improve the quality of their medical care. Veradigm is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Veradigm stock

Equity Turnover of Veradigm is 0.58 in 2024.

Equity Turnover of Veradigm changed from 0.58 to 0.58, representing a 0.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Equity Turnover Veradigm since 2006 – with annual values, charts, and detailed analysis.

Equity turnover measures how efficiently a company uses shareholders' equity to generate revenue. It is a component of the DuPont analysis framework.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Equity Turnover's Veradigm with sector peers and the industry average to assess whether it is attractive.

To evaluate Equity Turnover's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Equity Turnover.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Veradigm

All Key Metrics — Veradigm